FDA launches new AI-powered system to track drug and vaccine side effects nationwide
FIRST ON FOX: The Food and Drug Administration (FDA) rolled out a new platform, backed by artificial intelligence, that will streamline publicly accessible reporting of negative or unexpected health effects...
By Fox News · Fox News
FIRST ON FOX: The Food and Drug Administration (FDA) rolled out a new platform, backed by artificial intelligence , that will streamline publicly accessible reporting of negative or unexpected health effects linked to medicines, vaccines, cosmetics, animal food and other consumer products. The FDA Adverse Event Monitoring System (AEMS) began operation Tuesday and will consolidate outdated systems used to process millions of adverse event reports and produce results in real time for consumers to access online. "The FDA’s fragmented adverse event systems have wasted taxpayer dollars and created large blind spots in our post-market surveillance," FDA Commissioner Dr. Marty Makary told Fox News Digital in a statement. "We’re addressing this critical issue by conducting a major modernization initiative on an accelerated timeline." "Moving forward, the FDA will have a single, intuitive adverse event platform that will better equip us and any interested researcher to access key data and insights about the safety of products on the market," Makary added. DR. MAKARY, DR OZ: PEOPLE TALK ABOUT LOWERING HEALTHCARE COSTS, BUT THE TRUMP ADMINISTRATION IS DOING IT Adverse event reports are critical to determining the safety and effectiveness of certain drugs and products after they are approved for clinical trials and reach the wider consumer market, though the agency says the reports have been undermined due to current inefficient infrastructure. The general concept of AEMS is that consumers will be able to access the new website and search for FDA-approved cosmetics , drugs, vaccines or foods that have adverse effect reports as they are reported by healthcare professionals, consumers, manufacturers and user facilities for medical devices. The agency estimates that roughly 6 to 7 million adverse event reports per year are evaluated through a seven database system. The FDA says that the collective cost of utilizing the database is an estimated $37 million bill to taxpayers. AEMS…